Wang, Deli http://orcid.org/0000-0003-2474-6811
Kowalewski, Elaine Kearney http://orcid.org/0000-0002-7915-877X
Koch, Gary
Article History
Received: 7 December 2021
Accepted: 21 February 2022
First Online: 23 March 2022
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest. Nevertheless, the authors acknowledge that AbbVie has an Alzheimer's research program in the same drug class as the medicines in the clinical trials that are addressed by the analyses in this manuscript. In addition, as the manuscript indicates, the data structures and analyses that are necessary to support accelerated approval by a regulatory agency for a medicine for Alzheimer's disease are beyond the scope of this manuscript.